Oryon Cell Therapies

Oryon Cell Therapies Inc., founded in 2020 by Ole Isacson and Nikola Kojic, is an active private biotechnology company specializing in developing autologous stem cell-derived therapies using induced pluripotent stem cells primarily targeting neurodegenerative diseases such as retinal degeneration. The company's approach leverages cutting-edge cellular engineering technologies rooted deeply in academic research led by its scientifically renowned founders. While detailed pipeline data or commercial-stage products are not yet publicized—typical for an early-stage biotech—the firm represents a promising player within regenerative medicine focusing on personalized cellular therapeutics[3].